2Morrow and mHealth Technologies Partner to Help 100K Turkish Smokers

A new article has been published at prMac.

2Morrow and mHealth Technologies Partner to Help 100K Turkish Smokers - Published on 08/27/15

2Morrow, Inc. and mHealth Technologies announced the formation of a partnership to localize 2Morrow's SmartQuit smoking cessation app for the Turkish market. The goal is to reach at least 100,000 smokers over the next 3 years with the evidence-based program. The SmartQuit program was created in collaboration with researchers from Fred Hutchinson Cancer Research Center in Seattle and is the first app-based cessation program shown to be effective in a randomized control trial.

Kirkland, Washington - 2Morrow, Inc. and mHealth Technologies announced the formation of a partnership to localize 2Morrow's SmartQuit(R) evidence-based, smoking cessation app for the Turkish market. Healthcare reform, intensive awareness campaigns, and government policies have resulted in an impressive decrease in Turkey's smoking rates over the last decade, and an increase in those seeking help with quitting. As of 2013, about 14M people in Turkey still smoked and there is strong interest and support in further reducing that number. In addition, smartphone usage has doubled in the last couple of years and continues to increase quickly.

"About 96% of the world's smokers live outside the US," explains Brandon Masterson, CEO of 2Morrow Inc. "Mobile technology provides an excellent tool for distributing evidence-based programs like SmartQuit(R) to people around the globe. We are excited to partner with mHeath Technologies who specializes in finding best-in-class wellness technologies and localizing them for specific markets."

In a feasibility study done by 2Morrow, 83% of smokers reported that they would be more likely to use an app than call a quit line for help with quitting. Mobile is quickly becoming a preferred delivery method for many wellness programs, but few have been clinically tested. The SmartQuit(R) program was created in collaboration with researchers from Fred Hutchinson Cancer Research Center in Seattle and is the first app-based cessation program shown to be effective in a randomized control trial. To date, two clinical trials of SmartQuit have been completed and a new large randomized control trial is planned for next year making SmartQuit the most tested smoking cessation "app" on the market.

"When we saw the smoking cessation program from 2Morrow and its clinically proven effectiveness, we knew this would be a great fit for us. The Acceptance and Commitment Therapy (ACT) behavioral program developed by Dr. Bricker is an exciting new approach to addressing the cravings associated with smoking, and gives us a competitive advantage in the marketplace", said John Cannon, CEO of mHealth Technologies. "This program will help 100's of thousands of people in Turkey learn proven techniques to help them successfully quit smoking."

About mHealth Technologies:
mHealth Technologies develops and licenses best-in-class technology from the health and wellness space and migrates the technology to culturally appropriate products in foreign marketplaces. The products provide guidance and support to change behaviors in the areas of medication adherence, smoking cessation, weight loss, chronic disease management, depression and stress management.

2Morrow : http://www.2morrowinc.com/
mHealth Technologies : http://www.mhealth.com.tr/
SmartQuit Smoking Cessation App / Program: http://2morrowinc.com/smoking-cessation.php


2Morrow specializes in delivering research-based, behavior change programs via smartphone apps. We do this by creating leading-edge programs, based on the work of respected researchers and thought leaders, and powering them with our proprietary behavior change engine. With SmartQuit, 2Morrow has collaborated with a renowned cancer research institute to address nicotine addiction. The program is distributed mainly via employers, states and other groups focused on population health. All Material and Software (C) Copyright 2015 2Morrow Inc. All Rights Reserved. Apple, the Apple logo, iPhone, iPod and iPad are registered trademarks of Apple Inc. in the U.S. and/or other countries. Other trademarks and registered trademarks may be the property of their respective owners.


*******
Link To Article: http://prmac.com/release-id-76424.htm
*******

---------------------------------------------------------------------------------
Note that you can alter delivered distributions at any time.

Login to your account on prMac to alter your channel selection, or to opt-out at any time.